MedPath

Azacitidine

These highlights do not include all the information needed to use AZACITIDINE FOR INJECTION safely and effectively. See full prescribing information for . AZACITIDINE for injection, Initial U.S. Approval: 2004

Approved
Approval ID

81366ec1-9689-4857-ded6-3d6342fe5132

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 26, 2023

Manufacturers
FDA

NorthStar RxLLC

DUNS: 830546433

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azacitidine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16714-927
Application NumberANDA201537
Product Classification
M
Marketing Category
C73584
G
Generic Name
Azacitidine
Product Specifications
Route of AdministrationSUBCUTANEOUS, INTRAVENOUS
Effective DateDecember 26, 2023
FDA Product Classification

INGREDIENTS (2)

AzacitidineActive
Quantity: 100 mg in 1 1
Code: M801H13NRU
Classification: ACTIB
mannitolInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.